NovoCodex

company

About

NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.

Details

Last Funding Type
Series A
Last Funding Money Raised
¥400M
Industries
Clinical Trials,Health Care,Product Research
Founded date
Jan 1, 2015
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥400M
NovoCodex has raised a total of ¥400M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 19, 2021 Series A ¥400M 1 Lilly Asia Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NovoCodex is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Yes Series A